Literature DB >> 10377227

Benzodiazepine receptor ligands. 4. Synthesis and pharmacological evaluation of 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxides.

A Costanzo1, G Guerrini, G Ciciani, F Bruni, S Selleri, B Costa, C Martini, A Lucacchini, P M Aiello, A Ipponi.   

Abstract

The synthesis of new 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2, 4]benzotriazine 5-oxides and their binding activities at the central benzodiazepine receptor (BZR) are reported. The derivatives substituted at the 3-position with electron-rich five-membered rings, such as pyrrole 11, 2-thiophene 13c, or 3-thiophene 13d, showed good affinity values for BZR. In in vivo tests the 3-(thien-3-yl)-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxide (13d) showed selective anticonvulsant activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377227     DOI: 10.1021/jm981126y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands.

Authors:  Victor W Pike; Sabrina Taliani; Talakad G Lohith; David R J Owen; Isabella Pugliesi; Eleonora Da Pozzo; Jinsoo Hong; Sami S Zoghbi; Roger N Gunn; Christine A Parker; Eugenii A Rabiner; Masahiro Fujita; Robert B Innis; Claudia Martini; Federico Da Settimo
Journal:  J Med Chem       Date:  2010-12-06       Impact factor: 7.446

2.  3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.

Authors:  Alessia Scatena; Francesco Fornai; Maria Letizia Trincavelli; Sabrina Taliani; Simona Daniele; Isabella Pugliesi; Sandro Cosconati; Claudia Martini; Federico Da Settimo
Journal:  ACS Chem Neurosci       Date:  2011-06-10       Impact factor: 4.418

Review 3.  Rational approaches for the design of various GABA modulators and their clinical progression.

Authors:  Kavita Bhagat; Jatinder V Singh; Piyusha P Pagare; Nitish Kumar; Anchal Sharma; Gurinder Kaur; Nihar Kinarivala; Srinivasa Gandu; Harbinder Singh; Sahil Sharma; Preet Mohinder S Bedi
Journal:  Mol Divers       Date:  2020-03-13       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.